These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 9528691
1. The formation and repair of cisplatin-DNA adducts in wild-type and cisplatin-resistant L1210 cells: comparison of immunocytochemical determination with detection in isolated DNA. Blommaert FA, Floot BG, van Dijk-Knijnenburg HC, Berends F, Baan RA, Schornagel JH, den Engelse L, Fichtinger-Schepman AM. Chem Biol Interact; 1998 Jan 30; 108(3):209-25. PubMed ID: 9528691 [Abstract] [Full Text] [Related]
2. Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells. Blommaert FA, van Dijk-Knijnenburg HC, Dijt FJ, den Engelse L, Baan RA, Berends F, Fichtinger-Schepman AM. Biochemistry; 1995 Jul 04; 34(26):8474-80. PubMed ID: 7599137 [Abstract] [Full Text] [Related]
3. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells. Gibbons GR, Kaufmann WK, Chaney SG. Carcinogenesis; 1991 Dec 04; 12(12):2253-7. PubMed ID: 1747924 [Abstract] [Full Text] [Related]
4. Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients. Hill BT, Scanlon KJ, Hansson J, Harstrick A, Pera M, Fichtinger-Schepman AM, Shellard SA. Eur J Cancer; 1994 Dec 04; 30A(6):832-7. PubMed ID: 7917544 [Abstract] [Full Text] [Related]
6. Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides. Terheggen PM, Floot BG, Lempers EL, van Tellingen O, Begg AC, den Engelse L. Cancer Chemother Pharmacol; 1991 Dec 04; 28(3):185-91. PubMed ID: 1855275 [Abstract] [Full Text] [Related]
7. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry. Harrington CF, Le Pla RC, Jones GD, Thomas AL, Farmer PB. Chem Res Toxicol; 2010 Aug 16; 23(8):1313-21. PubMed ID: 20666396 [Abstract] [Full Text] [Related]
9. Role of carrier ligand in platinum resistance in L1210 cells. Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG. Cancer Res; 1990 Oct 15; 50(20):6497-501. PubMed ID: 2208108 [Abstract] [Full Text] [Related]
10. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Yoshida M, Khokhar AR, Siddik ZH. Cancer Res; 1994 Jul 01; 54(13):3468-73. PubMed ID: 8012968 [Abstract] [Full Text] [Related]
18. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. Strandberg MC, Bresnick E, Eastman A. Chem Biol Interact; 1982 Mar 15; 39(2):169-80. PubMed ID: 7199396 [Abstract] [Full Text] [Related]
20. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. Hill BT, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Bedford P. Int J Radiat Oncol Biol Phys; 1990 Jul 15; 19(1):75-83. PubMed ID: 2380098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]